Biotech · Private company · Malvern, PA, US
Progenra, Inc.
Track this companyFree. Adds Progenra, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Ubiquitin pathway modulators as novel antituberculosis drugsFiscal year 2025 · $302.4KNIH RePORTER 1R43AI191788-01 · fetched Nov 12, 2026
- Ubiquitin pathway modulators for treating pancreatitisFiscal year 2024 · $269.6KNIH RePORTER 1R43DK138712-01 · fetched Nov 12, 2026